# OnCo record elironrasib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/elironrasib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "elironrasib" ;
  schema:name "Elironrasib"@en ;
  schema:description "A next-generation KRAS G12C drug that hits the active form of the protein, from the same company as daraxonrasib."@en ;
  schema:url <https://onco.cc/drugs/elironrasib/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=RMC-6291> ;
  onco:status "phase-2" ;
  onco:modality "Small-molecule RAS(ON) G12C-selective inhibitor" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/kras-g12c-pdac/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/kras/> ;
  onco:companies <https://onco.cc/companies/revolution-medicines/> ;
  onco:pathways <https://onco.cc/pathways/ras-mapk/> ;
  onco:trials <https://onco.cc/trials/nct07397338/>, <https://onco.cc/trials/nct06162221/>, <https://onco.cc/trials/nct06128551/> .